Lesbians may have a higher incidence of certain cancers than heterosexual women, according to research published in Cancer. Researchers evaluated cancer incidence by sexual orientation using data on ...

Adding abemaciclib to first-line nonsteroidal aromatase inhibitor treatment does not provide a significant improvement in OS for patients with HR+/HER2- advanced breast cancer, updated data suggest.

Minimal residual disease surveillance may predict long-term progression and survival outcomes in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant.

Researchers found that chatbots’ responses scored better than oncologists’ responses in terms of overall quality, empathy, and readability. Two of the 3 chatbots also produced responses that were more ...

Experts point to a clear incentivization of quantity, rather than quality, of research output — both with the publishing ...

Some experts have said greater oversight of laboratory-developed tests will have negative impacts on cancer research and care ...

In April, the US Food and Drug Administration announced pipeline updates for several drugs intended to treat cancers.

The Mark Cuban Cost Plus Drug Company has the potential to reduce Medicare Part D spending for cancer drugs, data suggest.

The FDA has approved a kit that will allow women to collect their own vaginal sample for HPV screening, a move that could increase early detection in those at risk of cervical cancer.

Merck has decided to discontinue the vibostolimab-pembrolizumab coformulation arm of the phase 3 KeyVibe-010 trial.

Non-Hispanic Black patients with melanoma present with more advanced disease than non-Hispanic White patients, data suggest.

Trans-inclusive language can help clinicians promote accessible and equitable care in traditional women's health care spaces.